The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription
about
Human metapneumovirus M2-2 protein inhibits innate cellular signaling by targeting MAVSRespiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunityIn Hot Pursuit of the First Vaccine Against Respiratory Syncytial VirusHuman Metapneumovirus: lessons learned over the first decadeInitiation and regulation of paramyxovirus transcription and replicationModulation of host adaptive immunity by hRSV proteinsRecent vaccine development for human metapneumovirusHost cytoskeleton in respiratory syncytial virus assembly and buddingRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Identification of temperature-sensitive mutations in the phosphoprotein of respiratory syncytial virus that are likely involved in its interaction with the nucleoprotein.Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzeesIdentification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity.Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicityFunctional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus.Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo.Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viabilityGranulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells.Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidatesSurface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells.Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription.Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymeraseProtein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly.Animal pneumoviruses: molecular genetics and pathogenesis.Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virusMapping the transcription and replication promoters of respiratory syncytial virusRecombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positionsA single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challengeOverexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replicationA cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virusA systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus.The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon responseNonsegmented negative-strand viruses as vaccine vectors.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsRespiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trialsGenomic analysis of four human metapneumovirus prototypesIdentification of a novel virulence factor in recombinant pneumonia virus of mice.RSV604, a novel inhibitor of respiratory syncytial virus replicationThe role of reverse genetics in the development of vaccines against respiratory viruses.New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.Viral and host factors in human respiratory syncytial virus pathogenesis.
P2860
Q24299636-8A7DA1BD-52BE-44ED-A6EF-086A8DA2DE75Q24676109-9E70AA40-9E78-4DC3-BD7A-BC44A5C0C97BQ26748856-547467A9-E1C7-4FD3-A067-1EEC214B286DQ26822938-2154A2A9-52B0-435B-B0B3-51C9189C9E01Q26851684-1388CD84-99A4-429B-A9DA-192C22BFFE8EQ27022693-D0881D91-51C5-42DE-A2A2-C4F1BC68CA4CQ27023742-7FD8C4F8-7477-4036-9478-26AE24B36708Q28067634-497B017A-68E3-4373-A2C3-6D56E2000E11Q30240274-826C3DCD-5E35-4459-8AF0-CDB9E505EE6CQ30818098-766819B7-6917-45D9-9E0B-FBB058F0B553Q33605207-3C7D8908-13E7-4DB7-97A1-0EFA2E1CE244Q33782234-9EF13B5C-8272-4293-AAEE-89A1114A2DFCQ33788724-E4ED6313-6A02-4FCA-A456-030D3DEC656FQ33806735-64839F57-EF72-4DB8-AEA3-3988C691B92CQ33826547-FCC351D7-C429-45DD-92B6-AD67CA45DD84Q33849620-E8F53485-0856-4EF7-891F-AC240E2ED77AQ33870105-9B9958A8-9481-48D6-BD6B-1E2A52F53D6BQ33984333-9C564889-46D5-45B8-9976-857E0C8AF907Q34025263-FFA5C8AA-F856-40F8-A2EE-27E25A808E74Q34044597-84D80510-FDB9-497E-BB23-7E0B40BA41E4Q34045568-3D9625C8-65A0-4FED-9C91-D20A9858E726Q34122163-54DBC21B-ECA7-4887-958F-2BD96EA24AD5Q34313560-0B0F1A91-5457-473C-AD5D-6C70D0A278C8Q34320755-66FA1A03-C78D-49DB-917D-D850312D4B17Q34331065-8AB251A2-9447-4B39-98A8-826B973C98BFQ34359826-C06F3588-3980-4F19-AC8A-6D102D8F1B6AQ34434713-636C47F7-237D-4026-A7D1-1A448FC2ABABQ34463539-6903E4A1-4FDD-4DD2-A0A8-F2C3488AB3CBQ34542805-F9EBA9FE-766A-4F89-84AC-39FD0BFDAC41Q34626385-977841AE-C21E-4529-8949-F085E033F3FDQ34651391-9CF9ADE2-635E-401C-BF8F-5A972C66D1A1Q35139219-FF71499B-85D0-498E-B69C-11599F88857FQ35566601-8BD07701-F44B-48E7-ADD6-043C564ED513Q35761061-8277EF98-786D-48A8-A9D9-834372C28EE8Q35945710-355A29E0-29FC-41F5-86D2-F9ED3C01422BQ35948067-1EA0206B-36CB-4F3C-A38E-301C08405A5CQ36094843-750B5909-3195-45C8-B790-566B5A998D51Q36099468-B3F6E75A-522D-4166-B50A-B6E92A632851Q36237057-7B4301DB-201B-45E2-9D4E-00E10146B964Q36483836-D92DCB1A-C143-4BF9-8A4B-B3812EE4C41B
P2860
The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
The M2-2 protein of human resp ...... replication and transcription
@ast
The M2-2 protein of human resp ...... replication and transcription
@en
type
label
The M2-2 protein of human resp ...... replication and transcription
@ast
The M2-2 protein of human resp ...... replication and transcription
@en
prefLabel
The M2-2 protein of human resp ...... replication and transcription
@ast
The M2-2 protein of human resp ...... replication and transcription
@en
P2860
P356
P1476
The M2-2 protein of human resp ...... replication and transcription
@en
P2093
Bermingham A
Collins PL
P2860
P304
11259-11264
P356
10.1073/PNAS.96.20.11259
P407
P577
1999-09-01T00:00:00Z